Microcystic Meningioma: Atypical Meningioma Revisited. Rare Case Report with Review of Literature
Article Sidebar
Main Article Content
Abstract
Meningiomas, classical extra-axial dural-based tumors of the meninges, have well-documented classical imaging features and signs on CT and MRI. Most meningiomas are classical lesions with prompt diagnosis on imaging and generally exhibit benign outcomes with slow growth patterns. The latest WHO classification of tumors in 2021 has classified 15 subtypes of meningiomas, and while classical meningiomas are WHO Grade 1 tumors, grading between varying subtypes varies between WHO Grades 1 and 3. The microcystic meningioma is a rare and atypical subtype of meningioma that has been sparsely documented in literature. In this case report, we revisit this rare subtype of meningioma with a brief review of literature.
Article Details
Copyright (c) 2025 Gupta K.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231–51. Available from: https://doi.org/10.1093/neuonc/noab106
Kuchna I, Matyja E, Wierzba-Bobrowicz T, Mazurowski W. Microcystic meningioma – a rarely occurring morphological variant of meningioma. Folia Neuropathol. 1994;32:259–63. Available from: https://pubmed.ncbi.nlm.nih.gov/7889343/
Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993;3(3):255–68. Available from: https://doi.org/10.1111/j.1750-3639.1993.tb00752.x
Toland A, Huntoon K, Dahiya SM. Meningioma: A Pathology Perspective. Neurosurgery. 2021;89(1):11–21. Available from: https://doi.org/10.1093/neuros/nyab001
Michaud J, Gagne F. Microcystic meningioma. Clinicopathologic report of eight cases. Arch Pathol Lab Med. 1983;107(2):75–80. Available from: https://pubmed.ncbi.nlm.nih.gov/6687423/
Paek SH, Kim SH, Chang KH, Park CK, Kim JE, Kim DG, et al. Microcystic meningiomas: radiological characteristics of 16 cases. Acta Neurochir (Wien). 2005;147(9):965-72; discussion 972. Available from: https://doi.org/10.1007/s00701-005-0578-3
Kim S, Kim D, Kim CY, Choe G, Chang KH, Jung HW. Microcystic Meningioma: The Characteristic Neuroradiologic Findings. J Korean Neurosurg Soc. 2003;35(4):401–6. Available from: https://jkns.or.kr/upload/pdf/0042003201.pdf
Chen CJ, Tseng YC, Hsu HL, Jung SM. Microcystic meningioma: importance of obvious hypointensity on T1-weighted magnetic resonance images. J Comput Assist Tomogr. 2008;32(1):130–4. Available from: https://doi.org/10.1097/rct.0b013e318064f127
Kulanthaivelu K, Lanka V, Chandran C, Nandeesh BN, Tiwari S, Mahadevan A, et al. Microcystic Meningiomas: MRI‐Pathologic Correlation. J Neuroimaging. 2020;30(4):460–7. Available from: https://doi.org/10.1111/jon.12743
Elster AD, Challa VR, Gilbert TH, D N Richardson, J C Contento. Meningiomas: MR and histopathologic features. Radiology. 1989;170(3):857–62. Available from: https://doi.org/10.1148/radiology.170.3.2916043
Kaplan RD, Coons S, Drayer BP, Bird CR, Johnson PC. MR characteristics of meningioma subtypes at 1.5 tesla. J Comput Assist Tomogr. 1992;16(3):366–72. Available from: https://doi.org/10.1097/00004728-199205000-00006
Calderon W, Martinez E, Auger C, Rovira A. Microcystic Meningioma: Eurorad. 2022. Available from: https://www.eurorad.org/case/17437
Paek SH, Kim SH, Chang KH, Park CK, Kim JE, Kim DG, et al. Microcystic meningiomas: radiological characteristics of 16 cases. Acta Neurochir (Wien). 2005;147(9):965–72. Available from: https://doi.org/10.1007/s00701-005-0578-3
Lam Shin Cheung V, Kim A, Sahgal A, Das S. Meningioma recurrence rates following treatment: a systematic analysis. J Neurooncol. 2017;136(2):351–61. Available from: https://doi.org/10.1007/s11060-017-2659-6
Ostrom QT, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2016–2020. Neuro Oncol. 2023;26(Suppl 1):iv1–iv153. Available from: https://doi.org/10.1093/neuonc/noaa200
Haddad AF, Young JS, Kanungo I, Sudhir S, Chen JS, Raleigh DR, et al. WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index. Front Oncol. 2020 28;10:1522. Available from: https://doi.org/10.3389/fonc.2020.01522
Barton E, Black KL, Sughrue ME. Ki-67 is a predictive marker of recurrence for WHO grade II meningiomas. Clin Neurol Neurosurg. 2024;237:107666. Available from: https://doi.org/10.1016/j.clineuro.2024.107666
Kumar A, Kasala VP, Bhatia A, Sable MN, Vij M, Khandelwal N, et al. Microcystic meningiomas: MRI–pathologic correlation. J Neuroimaging. 2020;30(5):622–8. Available from: https://doi.org/10.1111/jon.12743